What question did this study set out to answer?

The research aims to explore the mechanisms behind YAP/TAZ-mediated angiogenesis and develop therapeutic strategies for its treatment.

July 4, 2026Naunyn-Schmiedeberg s Archives of Pharmacology0 citationsOpen Access

Young Investigator Award 2026: Integrative mechanistic insights into YAP/TAZ-mediated angiogenesis and its therapeutic implications

YWYohanes Cakrapradipta WibowoHelmholtz Association of German Research Centres

Key Points

The research aims to explore the mechanisms behind YAP/TAZ-mediated angiogenesis and develop therapeutic strategies for its treatment.
Investigated molecular pathways of YAP/TAZ in angiogenesis
Developed therapeutic strategies based on mechanistic insights
Presented findings at the Young Investigator Award ceremony
Demonstrated a novel mechanism of action for YAP/TAZ in promoting angiogenesis
Proposed potential therapeutic interventions to target pathological angiogenesis
Received recognition for innovative research in experimental pharmacology

Abstract

The Young Investigator Award or "Nachwuchspreis der DGPT" (formerly the Fritz Külz Award) is awarded by the German Society for Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie e.V./DGPT) to young scientists in recognition of their outstanding work in experimental pharmacology and toxicology. The Young Investigator Award in 2026 was awarded to Dr. Dr. Yohanes Cakrapradipta Wibowo from the Medical Faculty Mannheim of Heidelberg University for his previous PhD research, which was supervised by the late Prof. Dr. Thomas Wieland. In this work, Dr. Wibowo uncovered a new mechanistic insight into angiogenesis and proposed a therapeutic strategy for treating pathological angiogenesis. This article provides an overview of Dr. Wibowo's research.

问 AI

Bookmark

View Full Paper